- Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantationE Mor
Rabin Medical Center, Petah Tikva, Israel
Ann Intern Med 129:643-53. 1998..To review the treatment of cirrhotic patients with hepatocellular carcinoma in the era of liver transplantation and to determine the most appropriate approach to the treatment of patients at different stages of disease...
- Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantationZ Ben-Ari
The Liver Institute, Department of Medicine D, Rabin Medical Center, Beilinson Campus, PO Box 102, Petah Tiqva 49100, Israel
Liver Transpl 7:113-7. 2001....
- Association of post-liver transplantation diabetes mellitus with hepatitis C virus infectionH Schmilovitz-Weiss
Gastroenterology Unit, Rabin Medical Center, Petah Tikva, Israel
Transplant Proc 35:667-8. 2003
- Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literatureZ Ben-Ari
Liver Institute and Department of Medicine D, Rabin Medical Center, Beilinson Campus, Sackler School of Medicine, Tel Aviv University, Petah Tikva, Israel
J Intern Med 253:544-52. 2003..To analyse the results of lamivudine therapy on suppression of hepatitis B virus (HBV) replication before transplantation and on preventing graft reinfection postoperatively...
- Defibrotide for the treatment of veno-occlusive disease after liver transplantationE Mor
Department of Transplantation, Rabin Medical Center, Beilinson Campus, Petah Tiqva 49 100, Israel
Transplantation 72:1237-40. 2001..Neither patient had side effects from the drug. CONCLUSIONS: Defibrotide is a promising drug for the treatment of VOD after liver transplantation and needs to be evaluated in large, prospective studies...
- Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocolR Rahamimov
Department of Transplantation, Rabin Medical Center, Beilinson Campus, Petah-Tiqwa, Israel
Transplant Proc 35:653-4. 2003
- Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantationZ Ben-Ari
The Liver Institute, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
Transplant Proc 35:612-3. 2003
- Magnetic resonance cholangiopancreatography for the accurate diagnosis of biliary complications after liver transplantation: comparison with endoscopic retrograde cholangiography and percutaneous transhepatic cholangiography - long-term follow-upL H Katz
Liver Institute and Department of Medicine D, Rabin Medical Center, Petah Tikva, Israel
Clin Transplant 24:E163-9. 2010..We recommend that MRCP be the diagnostic imaging modality of choice in this setting, reserving direct cholangiography for therapeutic procedures...
- De novo tumors after liver transplantation: a single-center experienceH Schmilovitz-Weiss
Gastroenterology Unit, Rabin Medical Center, Petah Tiqva, Israel
Transplant Proc 35:665-6. 2003
- Mucormycosis in a liver allograft: salvage re-transplantation and targeted immunosuppressive managementM Gurevich
Department of Transplantation, Rabin Medical Center, Beilinson Hospital, Petach Tiqwa, Israel
Transpl Infect Dis 14:E97-101. 2012..At 3-year follow-up, the child maintained normal graft function. We conclude that discontinuation of immunosuppression combined with a modern antifungal regimen may allow salvage re-transplantation in patients with liver mucormycosis...
- Switching from tacrolimus to sirolimus halts the appearance of new sebaceous neoplasms in Muir-Torre syndromeZ Levi
Department of Gastroenterology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel
Am J Transplant 7:476-9. 2007..Further studies on the potential use of sirolimus for the treatment of de novo tumors in immunosuppressed kidney transplant recipients with HNPCC are warranted...
- Extension of the organ pool in kidney transplantation: first year experience of the Israel Transplant CenterE Mor
Department of Transplantation, Rabin Medical Center, Petah Tiqva, Israel
Isr Med Assoc J 2:302-5. 2000..Over a 12 month period, the Israel Transplant Center doubled the number of donors by assigning a nurse coordinator to each of 22 hospitals around the country and by using kidneys from elderly donors...
- Cholestasis and hypoalbuminemia as predictors of outcome after liver transplantationE Mor
Department of Transplantation, Petah-Tikwa, Israel
Transplant Proc 35:617-8. 2003
- Cathepsin B inactivation attenuates the apoptotic injury induced by ischemia/reperfusion of mouse liverZ Ben-Ari
Liver Institute and Department of Medicine D, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
Apoptosis 10:1261-9. 2005..The aim of this study was to ascertain if cathepsin B inactivation attenuates the apoptotic injury due to I/R in mouse liver...
- BK polyoma virus nephropathy in kidney transplant recipient: the role of new immunosuppressive agentsR Rahamimov
Department of Nephrology, Rabin Medical Center, Beilinson Campus, Petah-Tiqva, Israel
Transplant Proc 35:604-5. 2003
- Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: retrospective observational studyH Green
Department of Nephrology and Hypertension, Rabin Medical Center, Beilinson Campus, Petah Tikva, 49100, Israel
Eur J Clin Microbiol Infect Dis 32:127-31. 2013..We observed no benefit for the antibiotic treatment of AB in the short- and long-term follow-up. A prospective observational study is needed...
- Percutaneous balloon dilatation for the treatment of early and late ureteral strictures after renal transplantation: long-term follow-upGil N Bachar
Department of Radiology, Interventional Radiology Unit, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
Cardiovasc Intervent Radiol 27:335-8. 2004..PBD is a safe and simple tool for treating ureteral strictures and procedure-related morbidity is low. It can serve as an initial treatment in patients with early or late ureteral strictures after renal transplantation...
- Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipientsZ Ben-Ari
Liver Institute, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel
Transplant Proc 35:609-11. 2003
- Parenteral fish oil administered to heart-beating organ donors and to renal transplant recipients: effects on renal functionV Zolotarski
Department of General Intensive Care, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel
Transplant Proc 35:624. 2003
- The role of nutritional support in transplant recipients: two case reportsR Anbar
Department of Nutrition, Petah-Tiqwa, Israel
Transplant Proc 35:614-6. 2003
- Preliminary results of non-cross-matched "old for old" kidney transplantationR Rahamimov
Nephrology Committee Israel Transplant Organization, Petah-Tiqva, Israel
Transplant Proc 35:647-8. 2003
- Mucormycosis of the renal allograft: case report and review of the literatureA Chkhotua
Institute of Urology, Tbilisi, Georgia
Transpl Int 14:438-41. 2001..Fungal colonization may occur during transplantation. A high index of suspicion, leading to early diagnosis and initiation of antifungal treatment, in addition to graft nephrectomy, are keys to a more favorable outcome...
- Primary hyperoxaluria type 1: improved outcome with timely liver transplantation: a single-center report of 36 childrenR Shapiro
Pediatric Gastroenterology and Nephrology Units, Schneider Children's Medical Center, Petach-Tikva, 49100, Israel
Transplantation 72:428-32. 2001..Combined liver-kidney transplantation is suggested for children with end-stage renal disease...
- Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in childrenR Shapira
Pediatric Gastroenterology Institute, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel
Transplantation 72:333-6. 2001..No adverse effects of the drug were noted. CONCLUSION: Lamivudine is beneficial and well tolerated in children with HBV infection after liver transplantation...
- Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipientsA R Tambur
Department of Immunology, 1577 Jelke, Rush Medical College, 1653 W Congress Parkway, Chicago, IL 60612, USA
Transplantation 71:1475-80. 2001..The objective of this study was to analyze the role of cytokine allelic variations in susceptibility to early graft rejection episodes and recurrence of hepatitis C infection in liver transplant (LTx) recipients...